Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VERA | AMGN | VRTX | REGN | BMY |
| Company | Vera Therapeutics Inc Cl A | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 42.92 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 43.09 | 278.52 | 404.07 | 936.47 | 44.42 |
| Low | 41.52 | 275.10 | 398.46 | 891.30 | 43.33 |
| Last | 43.19 | 276.00 | 403.13 | 935.69 | 44.00 |
| Change | +0.87 | -1.37 | +0.99 | +32.21 | -0.21 |
| % Change | +2.06% | -0.49% | +0.25% | +3.57% | -0.48% |
| Volume | 129,845 | 837,635 | 427,831 | 429,825 | 6,743,532 |
| 20-Day Average Volume | 1,263,926 | 2,160,494 | 972,066 | 475,879 | 13,837,960 |
| Previous Close | 42.32 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 41.09 | 270.11 | 398.89 | 908.72 | 47.84 |
| 20-Day Raw Stochastic | 46.00% | 82.67% | 66.97% | 71.82% | 7.75% |
| 20-Day Relative Strength | 53.10% | 51.93% | 49.06% | 51.66% | 28.11% |
| Weighted Alpha | +82.54 | +14.07 | +15.38 | +21.67 | -36.69 |
| Today's Opinion | 64% Buy | 24% Sell | 8% Buy | 40% Buy | 88% Sell |
| Previous Opinion | 64% Buy | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.26% since 04/25/24 | +2.65% since 04/25/24 | +1.50% since 04/25/24 | +4.28% since 04/25/24 | -1.61% since 04/25/24 |
| Low | 38.40 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 43.85 on 05/01/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 934.94 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +4.43% since 04/02/24 | +0.11% since 04/02/24 | -1.40% since 04/02/24 | -2.71% since 04/02/24 | -16.61% since 04/02/24 |
| Low | 35.85 on 04/10/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 50.65 on 04/12/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +8.97% since 02/02/24 | -14.44% since 02/02/24 | -4.94% since 02/02/24 | -1.73% since 02/02/24 | -9.71% since 02/02/24 |
| Low | 35.85 on 04/10/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 50.78 on 03/01/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +325.32% since 11/02/23 | +3.72% since 11/02/23 | +7.20% since 11/02/23 | +13.44% since 11/02/23 | -13.98% since 11/02/23 |
| Low | 9.83 on 11/03/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 50.78 on 03/01/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,304,408 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 54,452 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -95,990,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -25,650,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.11 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.58 on 03/20/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |